-
Immunogenicity and Efficacy of Subcutaneous Infliximab Monotherapy vs Combination Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Anjie, S. I., Gecse, K. B., Meloni, C. M., Vidal-Itriago, A., löwenberg, M. & D'Haens, G. R., 2025, (E-pub ahead of print) In: Clinical Gastroenterology and Hepatology.Research output: Contribution to journal › Review article* › Academic › peer-review
-
Comparative Efficacy of Subcutaneous and Intravenous Infliximab and Vedolizumab for Maintenance Treatment of TNF-naive Adult Patients with Inflammatory Bowel Disease: A Systematic Literature Review and Network Meta-analysis
Peyrin-Biroulet, L., Bossuyt, P., Bettenworth, D., Loftus, E. V., Anjie, S. I., D’Haens, G., Saruta, M., Arkkila, P., Park, H., Choi, D., Kim, D. H. & Reinisch, W., May 2024, In: Digestive Diseases and Sciences. 69, 5, p. 1808-1825 18 p.Research output: Contribution to journal › Article* › Academic › peer-review
-
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case series
Anjie, S. I., Gecse, K. B., Ponsioen, C. Y., Löwenberg, M. & D’Haens, G. R., 1 Jan 2024, In: Therapeutic advances in gastroenterology. 17Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
